|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 2197 for Fgfr3

<< First    < Previous  |  Next >    Last >>
0.067s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Gene
Type: gene
Organism: chicken
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
GXD Expression      
Probe: MGI:5556219
Assay Type: Northern blot
Annotation Date: 2014-04-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1737323
Stage: TS23
Assay Id: MGI:5556256
Age: embryonic day 15.5
Specimen Label: Fgfr3
Detected: true
Specimen Num: 3
Protein
Organism: Mus musculus/domesticus
Length: 140  
Fragment?: false
GXD Expression    
Probe: MGI:6386983
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6387000
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: false
Specimen Num: 5
Publication
First Author: Su N
Year: 2010
Journal: Int J Biol Sci
Title: Generation of Fgfr3 conditional knockout mice.
Volume: 6
Issue: 4
Pages: 327-32
Publication
First Author: Moldrich RX
Year: 2011
Journal: Dev Dyn
Title: Fgfr3 regulates development of the caudal telencephalon.
Volume: 240
Issue: 6
Pages: 1586-99
Publication
First Author: Xie Y
Year: 2017
Journal: Int J Biol Sci
Title: FGFR3 deficient mice have accelerated fracture repair.
Volume: 13
Issue: 8
Pages: 1029-1037
Publication  
First Author: Lee YC
Year: 2017
Journal: Sci Rep
Title: Knock-in human FGFR3 achondroplasia mutation as a mouse model for human skeletal dysplasia.
Volume: 7
Pages: 43220
Publication
First Author: Garcia S
Year: 2013
Journal: Sci Transl Med
Title: Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Volume: 5
Issue: 203
Pages: 203ra124
Publication
First Author: Shazeeb MS
Year: 2018
Journal: Sci Rep
Title: Skeletal Characterization of the Fgfr3 Mouse Model of Achondroplasia Using Micro-CT and MRI Volumetric Imaging.
Volume: 8
Issue: 1
Pages: 469
Publication
First Author: Julien A
Year: 2020
Journal: Stem Cell Reports
Title: FGFR3 in Periosteal Cells Drives Cartilage-to-Bone Transformation in Bone Repair.
Volume: 15
Issue: 4
Pages: 955-967
Publication
First Author: Zhou S
Year: 2015
Journal: PLoS Genet
Title: FGFR3 Deficiency Causes Multiple Chondroma-like Lesions by Upregulating Hedgehog Signaling.
Volume: 11
Issue: 6
Pages: e1005214
Publication
First Author: Wen X
Year: 2016
Journal: J Biol Chem
Title: Chondrocyte FGFR3 Regulates Bone Mass by Inhibiting Osteogenesis.
Volume: 291
Issue: 48
Pages: 24912-24921
Publication
First Author: Foth M
Year: 2018
Journal: J Pathol
Title: FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Volume: 246
Issue: 3
Pages: 331-343
GXD Expression  
Probe: MGI:3687188
Assay Type: RNA in situ
Annotation Date: 2006-11-09
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1910624
Pattern: Regionally restricted
Stage: TS24
Assay Id: MGI:3687189
Age: embryonic day 16.5
Note: Expression was low in prechondrocytes and epiphyseal reserve chondroblasts and upregulated in columnar chondroblasts.
Specimen Label: 7 FGFR3 top
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:3687188
Assay Type: RNA in situ
Annotation Date: 2006-11-09
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:1910624
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:3687189
Age: embryonic day 16.5
Specimen Label: 7 FGFR3 bottom
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286620
Pattern: Not Specified
Stage: TS20
Assay Id: MGI:6451703
Age: embryonic day 12.5
Specimen Label: S1 FGFR3 E12.5
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286621
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6451703
Age: embryonic day 13.5
Specimen Label: S1 FGFR3 E13.5
Detected: true
Specimen Num: 2
GXD Expression  
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286020
Pattern: Regionally restricted
Stage: TS20
Assay Id: MGI:6451703
Age: embryonic day 12.5
Note: Expression on basal surface of distal airway epithelium.
Specimen Label: S1 FGFR3 E12.5
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:6451700
Assay Type: Immunohistochemistry
Annotation Date: 2020-08-26
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3286021
Pattern: Regionally restricted
Stage: TS21
Assay Id: MGI:6451703
Age: embryonic day 13.5
Note: Expression on basal surface of distal airway epithelium.
Specimen Label: S1 FGFR3 E13.5
Detected: true
Specimen Num: 2
Publication
First Author: Di Rocco F
Year: 2014
Journal: Hum Mol Genet
Title: FGFR3 mutation causes abnormal membranous ossification in achondroplasia.
Volume: 23
Issue: 11
Pages: 2914-25
Publication
First Author: Liu S
Year: 2008
Journal: J Am Soc Nephrol
Title: FGFR3 and FGFR4 do not mediate renal effects of FGF23.
Volume: 19
Issue: 12
Pages: 2342-50
Publication  
First Author: Loisay L
Year: 2023
Journal: JCI Insight
Title: Hypochondroplasia gain-of-function mutation in FGFR3 causes defective bone mineralization in mice.
Volume: 8
Issue: 12
Publication
First Author: Chen J
Year: 2005
Journal: Blood
Title: Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.
Volume: 106
Issue: 1
Pages: 328-37
Publication
First Author: Huang JY
Year: 2020
Journal: Sci Rep
Title: Enhanced FGFR3 activity in postmitotic principal neurons during brain development results in cortical dysplasia and axonal tract abnormality.
Volume: 10
Issue: 1
Pages: 18508
Publication
First Author: Pannier S
Year: 2010
Journal: Bone
Title: Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia.
Volume: 47
Issue: 5
Pages: 905-15
Publication  
First Author: Osawa Y
Year: 2017
Journal: Bone
Title: Activated FGFR3 promotes bone formation via accelerating endochondral ossification in mouse model of distraction osteogenesis.
Volume: 105
Pages: 42-49
Publication
First Author: Su N
Year: 2008
Journal: Biochem Biophys Res Commun
Title: Gain-of-function mutation of FGFR3 results in impaired fracture healing due to inhibition of chondrocyte differentiation.
Volume: 376
Issue: 3
Pages: 454-9
Publication
First Author: Kimura T
Year: 2018
Journal: Osteoarthritis Cartilage
Title: Proposal of patient-specific growth plate cartilage xenograft model for FGFR3 chondrodysplasia.
Volume: 26
Issue: 11
Pages: 1551-1561
Publication
First Author: Arnaud-Dabernat S
Year: 2007
Journal: Diabetes
Title: FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells.
Volume: 56
Issue: 1
Pages: 96-106
Publication
First Author: Kang W
Year: 2019
Journal: Stem Cell Reports
Title: Transient Redirection of SVZ Stem Cells to Oligodendrogenesis by FGFR3 Activation Promotes Remyelination.
Volume: 12
Issue: 6
Pages: 1223-1231
Publication  
First Author: Zhou S
Year: 2016
Journal: Sci Rep
Title: Conditional Deletion of Fgfr3 in Chondrocytes leads to Osteoarthritis-like Defects in Temporomandibular Joint of Adult Mice.
Volume: 6
Pages: 24039
Publication
First Author: Mugniery E
Year: 2012
Journal: Hum Mol Genet
Title: An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth.
Volume: 21
Issue: 11
Pages: 2503-13
Publication
First Author: Chen L
Year: 1999
Journal: J Clin Invest
Title: Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
Volume: 104
Issue: 11
Pages: 1517-25
Publication
First Author: Iwata T
Year: 2001
Journal: Hum Mol Genet
Title: Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice.
Volume: 10
Issue: 12
Pages: 1255-64
Publication
First Author: Lorget F
Year: 2012
Journal: Am J Hum Genet
Title: Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Volume: 91
Issue: 6
Pages: 1108-14
Publication  
First Author: Cornille M
Year: 2022
Journal: J Exp Med
Title: FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.
Volume: 219
Issue: 4
Publication
First Author: Dunois-Lardé C
Year: 2005
Journal: Mol Carcinog
Title: Absence of FGFR3 mutations in urinary bladder tumours of rats and mice treated with N-butyl-N-(-4-hydroxybutyl)nitrosamine.
Volume: 42
Issue: 3
Pages: 142-9
Publication
First Author: Usha AP
Year: 1997
Journal: Anim Genet
Title: Dwarfism in Dexter cattle is not caused by the mutations in FGFR3 responsible for achondroplasia in humans.
Volume: 28
Issue: 1
Pages: 55-7
Publication
First Author: Qi H
Year: 2014
Journal: Biochim Biophys Acta
Title: FGFR3 induces degradation of BMP type I receptor to regulate skeletal development.
Volume: 1843
Issue: 7
Pages: 1237-47
Publication
First Author: Matsushita T
Year: 2009
Journal: Hum Mol Genet
Title: FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Volume: 18
Issue: 2
Pages: 227-40
Publication
First Author: Martin L
Year: 2018
Journal: Hum Mol Genet
Title: Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia.
Volume: 27
Issue: 1
Pages: 1-13
Publication
First Author: Inglis-Broadgate SL
Year: 2005
Journal: Dev Biol
Title: FGFR3 regulates brain size by controlling progenitor cell proliferation and apoptosis during embryonic development.
Volume: 279
Issue: 1
Pages: 73-85
Publication
First Author: de Frutos CA
Year: 2007
Journal: Dev Cell
Title: Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias.
Volume: 13
Issue: 6
Pages: 872-83
Publication
First Author: Jin M
Year: 2012
Journal: Hum Mol Genet
Title: A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia.
Volume: 21
Issue: 26
Pages: 5443-55
Publication
First Author: Li H
Year: 2011
Journal: Am J Physiol Endocrinol Metab
Title: Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
Volume: 300
Issue: 3
Pages: E508-17
Publication
First Author: Wang Q
Year: 2001
Journal: Development
Title: Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains.
Volume: 128
Issue: 19
Pages: 3867-76
Publication
First Author: Kuang L
Year: 2020
Journal: Ann Rheum Dis
Title: FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice.
Volume: 79
Issue: 1
Pages: 112-122
Publication
First Author: Ota S
Year: 2016
Journal: Hum Mol Genet
Title: HDAC6 deficiency or inhibition blocks FGFR3 accumulation and improves bone growth in a model of achondroplasia.
Volume: 25
Issue: 19
Pages: 4227-4243
Publication
First Author: Hayashi T
Year: 2007
Journal: Dev Dyn
Title: Loss of Fgfr3 leads to excess hair cell development in the mouse organ of Corti.
Volume: 236
Issue: 2
Pages: 525-33
Publication
First Author: Iwata T
Year: 2000
Journal: Hum Mol Genet
Title: A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos.
Volume: 9
Issue: 11
Pages: 1603-13
Publication
First Author: Pannier S
Year: 2009
Journal: Biochim Biophys Acta
Title: Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia.
Volume: 1792
Issue: 2
Pages: 140-7
Publication
First Author: Jonquoy A
Year: 2012
Journal: Hum Mol Genet
Title: A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.
Volume: 21
Issue: 4
Pages: 841-51
Publication
First Author: Logié A
Year: 2005
Journal: Hum Mol Genet
Title: Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans.
Volume: 14
Issue: 9
Pages: 1153-60
Publication
First Author: Ran Q
Year: 2021
Journal: Transplant Cell Ther
Title: Loss of FGFR3 Accelerates Bone Marrow Suppression-Induced Hematopoietic Stem and Progenitor Cell Expansion by Activating FGFR1-ELK1-Cyclin D1 Signaling.
Volume: 27
Issue: 1
Pages: 45.e1-45.e10
Publication
First Author: Zhou ZQ
Year: 2015
Journal: Hum Mol Genet
Title: Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes.
Volume: 24
Issue: 6
Pages: 1764-73
Publication
First Author: Blak AA
Year: 2007
Journal: Dev Biol
Title: Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain.
Volume: 303
Issue: 1
Pages: 231-43
Publication
First Author: Pringle NP
Year: 2003
Journal: Development
Title: Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains.
Volume: 130
Issue: 1
Pages: 93-102
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6190278
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Fgfr3
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689421
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6190278
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Fgfr3
Detected: true
Specimen Num: 2
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6190278
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Fgfr3
Detected: true
Specimen Num: 3
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689426
Pattern: Not Specified
Stage: TS26
Assay Id: MGI:6190278
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Fgfr3
Detected: true
Specimen Num: 4
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Fgfr3
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Fgfr3
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:6172902
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689428
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6190278
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Fgfr3
Detected: true
Specimen Num: 7
Publication
First Author: Su N
Year: 2010
Journal: Hum Mol Genet
Title: Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.
Volume: 19
Issue: 7
Pages: 1199-210
Publication
First Author: Perez-Castro AV
Year: 1997
Journal: Genomics
Title: Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.
Volume: 41
Issue: 1
Pages: 10-6
Publication
First Author: Shung CY
Year: 2012
Journal: Hum Mol Genet
Title: Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II.
Volume: 21
Issue: 21
Pages: 4628-44
GXD Expression  
Probe: MGI:7733440
Assay Type: RNA in situ
Annotation Date: 2024-10-02
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1691022
Pattern: Regionally restricted
Stage: TS22
Assay Id: MGI:7734645
Age: embryonic day 14.5
Note: Fgfr3 was strongly expressed in the posterior region and not observed in the olfactory bulb.
Specimen Label: 1F
Detected: true
Specimen Num: 2
Publication
First Author: Ahmad I
Year: 2011
Journal: Dis Model Mech
Title: K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
Volume: 4
Issue: 4
Pages: 548-55
Publication
First Author: Jungnickel J
Year: 2005
Journal: Neuroscience
Title: Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants.
Volume: 134
Issue: 4
Pages: 1343-50
Publication      
First Author: Harris BS
Year: 2011
Journal: MGI Direct Data Submission
Title: A new spontaneous mutation in Fgfr3
Publication
First Author: Nakajima A
Year: 2003
Journal: Endocrinology
Title: Expression of fibroblast growth factor receptor-3 (FGFR3), signal transducer and activator of transcription-1, and cyclin-dependent kinase inhibitor p21 during endochondral ossification: differential role of FGFR3 in skeletal development and fracture repair.
Volume: 144
Issue: 10
Pages: 4659-68
Publication
First Author: Gonçalves D
Year: 2020
Journal: PLoS One
Title: In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia.
Volume: 15
Issue: 12
Pages: e0244368
Publication
First Author: Yamashita A
Year: 2014
Journal: Nature
Title: Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Volume: 513
Issue: 7519
Pages: 507-11
UniProt Feature
Begin: 529
Description: Phosphotyrosine; by FGFR3
Type: modified residue
End: 529
Publication
First Author: Wang Y
Year: 1999
Journal: Proc Natl Acad Sci U S A
Title: A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Volume: 96
Issue: 8
Pages: 4455-60
Publication  
First Author: Wagner BM
Year: 2021
Journal: JCI Insight
Title: Prevention of guanylyl cyclase-B dephosphorylation rescues achondroplastic dwarfism.
Volume: 6
Issue: 9
Publication
First Author: Segev O
Year: 2000
Journal: Hum Mol Genet
Title: Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice.
Volume: 9
Issue: 2
Pages: 249-58
Publication
First Author: Naski MC
Year: 1998
Journal: Development
Title: Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3.
Volume: 125
Issue: 24
Pages: 4977-88
Publication
First Author: Davidson D
Year: 2005
Journal: J Biol Chem
Title: Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis.
Volume: 280
Issue: 21
Pages: 20509-15
GXD Expression    
Probe: MGI:6386981
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6386998
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: true
Specimen Num: 5
GXD Expression    
Probe: MGI:6386982
Assay Type: RNase protection
Annotation Date: 2020-01-30
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1783828
Stage: TS28
Assay Id: MGI:6386999
Age: postnatal adult
Image: S2
Specimen Label: Fgfr3 null
Detected: true
Specimen Num: 5
Publication
First Author: Colvin JS
Year: 1996
Journal: Nat Genet
Title: Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
Volume: 12
Issue: 4
Pages: 390-7
Publication
First Author: Cho JY
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia.
Volume: 101
Issue: 2
Pages: 609-14
Publication
First Author: Lin T
Year: 2003
Journal: Hum Mol Genet
Title: A central nervous system specific mouse model for thanatophoric dysplasia type II.
Volume: 12
Issue: 21
Pages: 2863-71
Publication
First Author: Jungnickel J
Year: 2004
Journal: Mol Cell Neurosci
Title: Fibroblast growth factor receptor 3 signaling regulates injury-related effects in the peripheral nervous system.
Volume: 25
Issue: 1
Pages: 21-9
Publication
First Author: Twigg SR
Year: 2009
Journal: Dev Dyn
Title: Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome.
Volume: 238
Issue: 2
Pages: 331-42
Publication
First Author: Perez-Castro AV
Year: 1995
Journal: Genomics
Title: Genomic organization of the mouse fibroblast growth factor receptor 3 (Fgfr3) gene.
Volume: 30
Issue: 2
Pages: 157-62
Publication
First Author: Wuechner C
Year: 1996
Journal: Int J Dev Biol
Title: Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse.
Volume: 40
Issue: 6
Pages: 1185-8
Publication  
First Author: Piombo V
Year: 2018
Journal: Bone
Title: Signaling systems affecting the severity of multiple osteochondromas.
Volume: 111
Pages: 71-81